Lack of susceptibility of cells from patients with Fabry disease to productive infection with R5 human immunodeficiency virus

AIDS

Volumn 19, Issue 14, 2005, Pages 1543-1546

  Lund, Nicole ^a,b   Branch, Donald R ^a,b,c   Sakac, Darinka ^b   Lingwood, Clifford A ^a,e   Siatskas, Christopher ^d   Robinson, Chevalia J ^f   Brady, Roscoe O ^f   Medin, Jeffrey A ^a,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b DEFENCE RESEARCH AND DEVELOPMENT CANADA   (Canada)

^c UNIVERSITY HEALTH NETWORK   (Canada)

^d PRINCESS MARGARET HOSPITAL   (Canada)

^e HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^f NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GLOBOTRIAOSYLCERAMIDE; GLYCOSPHINGOLIPID;

ARTICLE; CELL ACTIVATION; CELL MEMBRANE; CONTROLLED STUDY; FABRY DISEASE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INFECTION SENSITIVITY; LIPOLYSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; T LYMPHOCYTE; VIRUS CELL INTERACTION; VIRUS REPLICATION; VIRUS STRAIN;

EID: 25844482999     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.aids.0000183521.90878.79     Document Type: Article

References (23)

1. Dalgleish AG, Beverley PC, Clapham PR, Crawford DH, Greaves MF, Weiss RA. The CD4(T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature 1984; 312:763-767.
2. Feng Y, Broder CC, Kennedy PE, Berger EA. HIV-1 entry cofactor: functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor. Science 1996; 272:872-877.
3. Alkhatib G, Combadiere C, Broder CC, Feng Y, Kennedy PE, Murphy PM, et al. CCCKR5: a RANTES, MIP-1 alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1. Science 1996; 272:1955-1958.
4. Hammache D, Pieroni G, Yahi N, Delezay O, Koch N, Lafont H, et al. Specific interaction of HIV-1 and HIV-2 surface envelope glycoproteins with monolayers of galactosylceramide and ganglioside GM3. J Biol Chem 1998; 273:7967-7971.
5. Bhat S, Mettus R, Reddy E, Ugen K, Srikanthan V, Williams W, et al. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res Human Retrovirus 1993; 9:175-181.
6. + cells. Virology 1998; 246:211-220.
7. Mylvaganam M, Lingwood CA. A convenient oxidation of natural glycosphingolipids to their "ceramide acids" for neoglycoconjugation: bovine serum albumin-glycoceramide acid conjugates as investigative probes for HIV coat protein gp120-glycosphingolipid interactions. J Biol Chem 1999; 274:20725-20732.
8. Mahfoud RG, Maresca M, Yahi N, Puigserver AFJ. Identification of a common sphingolipid-binding domain in Alzheimer, prion and HIV-1 proteins. J Biol Chem 2002; 277:11292-11296.
9. 3 and GM3). J Virol 1999; 73:5244-5248.
10. Nehete PN, Vela EM, Hossain MM, Sarkar AK, Yahi N, Fantini J, et al. A post-CD4-binding step involving interaction of the V3 region of viral gp120 with host cell surface glycosphingolipids is common to entry and infection by diverse HIV-1 strains. Antiviral Res 2002; 56:233-251.
11. Hug P, Lin HM, Korte T, Xiao X, Dimitrov DS, Wang JM, et al. Glycosphingolipids promote entry of a broad range of human immunodeficiency virus type 1 isolates into cell unes expressing CD4, CXCR4, and/or CCR5. J Virol 2000; 74:6377-6385.
12. Puri A, Hug P, Jernigan K, Barchi J, Kim H-Y, Hamilton J, et al. The neutral glycosphingolipid globotriaosylceramide promotes fusion mediated by a CD4-dependent CXCR4-utilizing HIV type 1 envelope glycoprotein. Proc Natl Acad Sci U S A 1998; 95:14435-14440.
13. Fantini J, Hammache D, Pieroni C, Yahi N. Role of glycosphingolipid microdomains in CD4-dependent HIV-1 fusion. Glycoconj J 2000; 17:199-204.
14. Manes S, Del Real G, Lacalle RA, Lucas P, Gomez-Mouton C, Sanchez-Palomino P, et al. Membrane raft microdomains mediate lateral assemblies required for HIV-1 infection. EMBO Rep 2000; 1:190-196.
15. Sorice M, Garofalo M, Misasi R, Longo A, Mattei V, Sale P, et al. Evidence for cell surface association between CXCR4 and ganglioside GM3 after gp120 binding in Sup T1 lymphoblastoid cells. FEBS Lett 2001; 506:55-60.
16. Rawat SS, Gallo SA, Eaton J, Martin TD, Ablan S, KewalRamani VN, et al. Elevated expression of GM3 in receptor-bearing targets confers resistance to human immunodeficiency virus type-1 fusion. J Virol 2004; 78:7360-7368.
17. Brady RO, Gal AE, Bradley RM, Martensson E, Warshaw AL, Laster L. Enzymatic defect in Fabry's disease. Ceramide-trihexosidase deficiency. N Engl J Med 1967; 276:1163-1167.
18. Branch DR, Mills GB. pp60c-src expression is induced by activation of normal human T lymphocytes. J Immunol 1995; 154:3678-3685.
19. Yousefi S, Ma XZ., Sinela R, Zhou YC, Sakac D, Bali M, et al. HIV-1 infection is facilitated in T cells by decreasing p56lck protein tyrosine kinase activity. Clin Exp Immunol 2003; 133:78-90.
20. Arab S, Lingwood CA. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol 1998; 177:646-660.
21. Khine AA, Tam P, Nutikka A, Lingwood CA. Brefeldin A and filipin distinguish two globotriaosyl ceramide/verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiology 2004; 14:701-712.
22. Johannes L, Pezo V, Mallard F, Tenza D, Wiltz A, Saint-Pol A, et al. Effects of HIV-1 Nef on retrograde transport from the plasma membrane to the endoplasmic reticulum. Traffic 2003; 4:323-332.
23. Puri V, Watanabe R, Dominguez M, Sun X, Wheatley CL, Marks DL, et al. Cholesterol modulates membrane traffic along the endocytic pathway in sphingolipid-storage diseases. Nat Cell Biol 1999; 1:386-388.